Back
Bumble Vs. Blueprint Medicines Industry Stock Comparison
Buy
68
BMBL
Bumble
Last Price:
$6.50
Seasonality Move:
-24.64%
Sell
50
BPMC
Blueprint Medicines
Last Price:
$128.10
Seasonality Move:
10.35%
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $128.25. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $128.25The current trend is moderately bullish and BPMC is experiencing slight selling pressure.
BMBL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 71.73 | Buy |
Chaikin Money Flow: | 8199236 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.1 - 5.86) | Buy |
Bollinger Bands (100): | (4.1 - 6.74) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.66 | Buy |
Relative Strength Index (14 RSI): | 75.28 | Buy |
Chaikin Money Flow: | -188052 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (106.53 - 132.13) | Buy |
Bollinger Bands (100): | (84.83 - 114.87) | Buy |
BMBL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.34 | Buy |
20-day SMA: | 5.41 | Buy |
50-day SMA: | 5.14 | Buy |
200-day SMA: | 6.44 | Buy |
8-day EMA: | 5.49 | Buy |
20-day EMA: | 5.39 | Buy |
50-day EMA: | 5.32 | Buy |
200-day EMA: | 6.64 | Sell |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.21 | Buy |
20-day SMA: | 123.84 | Buy |
50-day SMA: | 106.16 | Buy |
200-day SMA: | 96.43 | Buy |
8-day EMA: | 127.83 | Buy |
20-day EMA: | 122.76 | Buy |
50-day EMA: | 111.5 | Buy |
200-day EMA: | 99.07 | Buy |
Bumble Earnings Growth & BMBL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.88 per share, and an increase next year of $0.05 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Bumble Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |